Navigation Links
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
Date:5/27/2009

such development compounds will be approved for sale in any market. Nor can there be any guarantee that any of the existing products referred to in this release will be approved for any additional indications or labeling in any market. Neither can there be any guarantee that any of these compounds or products will achieve any particular levels of revenue in the future. In particular, management's expectations regarding compounds and products could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovat
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
2. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
3. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
4. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
5. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
6. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
7. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
8. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
9. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
10. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
11. Video: Answer to Curing a Failing Heart May Exist in Bodys Own Do-It-Yourself Repair Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  UL (Underwriters Laboratories), ... the U.S. Food and Drug Administration (FDA) has ... standards for medical devices incorporating lithium or nickel-based ... Standard for Household and Commercial Batteries, and UL ... Consensus standards are standards recognized by ...
(Date:7/22/2014)... , July 22, 2014  Vernalis plc (LSE: VER) and ... proof-of-concept (POC) for CCP-08, the third programme to ... cold collaboration. Under this collaboration, POC requires the ... human pilot comparative study against an immediate release ... Vernalis will make a milestone payment to Tris. ...
(Date:7/22/2014)... SAN MARCOS, Texas , July 22, 2014 Quantum ... Martin and Mr. John Heaton to the Board ... chaired by Dr. Ghassan Jabbour , QMC Chief Science Officer ... Dr. Michael Wong of Rice University and Mr. ... Japan . " Quantum Materials ...
Breaking Medicine Technology:Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... FORD, Pa., March 29, 2012 Endo (Nasdaq: ENDP ... Bihl, will step down as head of the Endo devices operating ... successor, a comprehensive executive search has been initiated. Mr. ... acquisition of AMS and was named President and Chief Executive Officer ...
... VIEW, Calif., March 29, 2012  Based on its ... market, Frost & Sullivan recognizes Sensear with the ... Product Differentiation Excellence for its "high-noise communication" devices, ... products protect hearing while still enabling the user ...
Cached Medicine Technology:Endo Announces Departure of American Medical Systems President 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
(Date:7/22/2014)... 22, 2014 Two individuals from Meditec, ... 2014 Association for Healthcare Documentation Integrity (AHDI) Awards. One ... is the sole nominee for both the Excellence in ... student, Linda Curia, is also nominated for the Rising ... transcription field for over 18 years in a wide-variety ...
(Date:7/22/2014)... York, NY (PRWEB) July 22, 2014 ... the Icahn School of Medicine at Mount Sinai have ... associated with the risk of developing schizophrenia, in the ... date, conducted with 80,000 people. The findings, published online ... may underlie schizophrenia, and could lead to new approaches ...
(Date:7/22/2014)... Hampshire (PRWEB) July 22, 2014 ... Dentistry officially opened the doors of its state-of-the-art, ... located in the heart of downtown San Francisco's South ... serving 10,000 patients a year. Those patients will now ... and sophisticated iKiosks . , Advanced Kiosks ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- Genetic fragments of the ... barn where an infected camel was kept, a new study ... to determine if Middle East Respiratory Syndrome (MERS) can be ... air samples over three consecutive days from a camel barn ... of the town of Jeddah, Saudi Arabia. The man later ...
(Date:7/22/2014)... stimulation treatments, like electroconvulsive therapy (ECT) and transcranial ... treatment of depression. Like antidepressant medications, however, they ... patient may receive several weeks of regular ECT ... Thus, there is an impetus to develop antidepressant ... field magnetic stimulation (LFMS) is one such potential ...
Breaking Medicine News(10 mins):Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 2Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 2Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 4Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2
... penis transplant, but were forced to remove it after the ... had lost his penis in an accident and was unable ... ,Doctors had attached a 10cm penis to the 44-year-old patient ... month's journal European Urology. 'Because of a severe psychological problem ...
... in Thiruvananthapuram said that there was no need to panic ... fever were reported in the city.// ,Health authorities said ... continue to pelt the state. The chikungunya scare so far ... not be confined to some pockets as mosquitoes are increasing ...
... for the treatment of mild to moderate obstructive ... The effectiveness of palatal implants for treatment of ... demonstrated in a number of clinical studies. Primarily, ... in apnea hypopnea index (AHI) as measured by ...
... cost the global economy up to $2 trillion or 4.8 ... said on Sunday.// ,In a worst-case scenario, 70 million ... the virus that had spread beyond East Asia to Europe, ... be the worst hit, with mortality rates double of those ...
... with now - a sharp rise in HIV/AIDS cases. While ... state, unofficial estimates peg the number at 25,000.// ... Features. The northern state lies in a low prevalence risk ... at 0.95 percent and among the low-risk groups at 0.06 ...
... be lost in several ways, not all may be healthy. ... is one of the healthy ways to lose weight.// ,The ... has found that eating high-fiber cereals not only help to ... magnesium and vitamin B-6. ,The study sponsored by Kraft, Dr. ...
Cached Medicine News:Health News:Palatal Implant Procedure Proven Effective in Eliminating Snoring 2Health News:Palatal Implant Procedure Proven Effective in Eliminating Snoring 3Health News:Kashmir Grapples with Growing AIDS 2Health News:Kashmir Grapples with Growing AIDS 3Health News:Weight Loss Healthier with a Diet of Whole Grain Cereals 2
... In certain hernia and soft tissue ... fascial defects, it is sometimes necessary ... one surface, while minimizing tissue attachment ... a soft, conformable, ePTFE sheet material ...
... Bard Dulex mesh is a dual-sided ePTFE ... side is a micro-porous structure designed to minimize ... side is a macro-porous structure designed to promote ... size of approximately 800 microns, which is nearly ...
... mesh is the first polypropylene mesh ... Visilex mesh directly addresses the critical ... specifically, it delivers maximum visibility, enhanced ... after insertion through the trocar.,Visilex mesh ...
... is constructed of knitted filaments of ... that used in PROLENE* Polypropylene Suture, ... The mesh is approximately,0.020 inches thick. ... suture, has been reported to be ...
Medicine Products: